StockWatch
·
Pharmaceuticals
Open Offer31 Jul 2026, 06:10 pm

Colinz Laboratories: Open Offer for 26% Stake at ₹54/Share

AI Summary

Saffron Capital Advisors Pvt Ltd, acting as the Manager to the Open Offer, has submitted a Letter of Offer to BSE for the public shareholders of Colinz Laboratories Ltd. The offer is made by Acquirer 1 (Annjana Dugar), Acquirer 2 (Likhitta Dugar), Acquirer 3 (Antariksh Dugar), and Padam Dugar (Person Acting In Concert). They aim to acquire up to 6,54,966 equity shares, representing 26% of the voting share capital, at a price of ₹54 per share. The total value of the open offer is ₹3,53,68,164. This open offer is being made pursuant to SEBI (SAST) Regulations, 2011, for substantial acquisition of shares and voting rights accompanied by a change in control. The offer is not conditional on minimum acceptance.

Key Highlights

  • Open offer to acquire 26% of Colinz Laboratories' voting share capital.
  • Offer price set at ₹54 per equity share.
  • Total offer value amounts to ₹3,53,68,164.
  • Acquisition involves a change in control, compliant with SEBI (SAST) Regulations.
  • Offer is not conditional on minimum acceptance levels.